The University of Nebraska Medical Center (UNMC) continues to bolster its research capabilities with the recent additions to its College of Dentistry, including Dr. H.M. Suranji Wijekoon, a researcher specializing in joint diseases and regenerative medicine. Dr. Wijekoon’s expertise promises to advance understanding and treatment of conditions like osteoarthritis and, more recently, nerve and tissue regeneration. This expansion reflects UNMC’s commitment to interdisciplinary research and translational medicine, bridging the gap between laboratory discoveries and patient care. The focus on Suranji Wijekoon and her work highlights a growing trend in biomedical research towards holistic approaches to complex health challenges.
Dr. Wijekoon’s journey to UNMC is marked by a diverse and impressive academic background. She initially earned her veterinary degree in Sri Lanka before pursuing a PhD at Hokkaido University in Japan, where her research centered on evaluating experimental drugs for osteoarthritis. This early work laid the foundation for her current focus on stem cell biology and regenerative medicine. She also completed internships at the University of Glasgow and Washington University in St. Louis, broadening her experience and network within the international scientific community. Her dedication to research is further demonstrated by her membership in the American Society for Bone and Mineral Research and publications in respected journals like PLOS One and Tissue Engineering.
From Joint Disease to Nerve Regeneration
While initially renowned for her work on osteoarthritis, Dr. Wijekoon’s research at UNMC has expanded to encompass large-gap nerve regeneration and composite tissue injuries. Currently working within Dr. Kumbar’s laboratory, she is focusing on innovative small-molecule drugs and related technologies to address these complex challenges. This shift reflects a growing understanding of the interconnectedness of different biological systems and the potential for applying regenerative medicine principles to a wider range of conditions. The team science project she’s involved in aims to develop technologies for reconstructing and regenerating composite tissue injuries, a significant advancement in the field of reconstructive surgery.
This expansion into nerve regeneration builds upon Dr. Kumbar’s established expertise in biomaterials and tissue engineering. Dr. Kumbar, a professor with tenure at UNMC, specializes in synthesizing and characterizing novel biomaterials for tissue engineering and drug delivery. His research focuses on fabricating micro- and nanostructures designed to enhance tissue regeneration and control drug delivery. The collaboration between Dr. Kumbar and Dr. Wijekoon represents a synergistic approach, combining expertise in biomaterials with expertise in cellular and molecular mechanisms of regeneration.
A Collaborative Approach to Research at UNMC
The arrival of Dr. Wijekoon and Dr. Kumbar, along with Dr. Sama Abdulmalik, to the UNMC College of Dentistry’s Department of Growth and Development in January 2025, signifies a strategic investment in research infrastructure. Dr. Abdulmalik’s work complements this effort, focusing on tendon tissue repair and regeneration using small-molecule drugs and stem cells. This collaborative environment fosters innovation and accelerates the translation of research findings into clinical applications. The university’s newsroom announced their appointments in November 2024, highlighting the significance of these additions to the college’s research capacity. UNMC News
Dr. Wijekoon is not only dedicated to advancing scientific knowledge but also to mentoring the next generation of researchers. She is committed to guiding undergraduate and graduate students in various areas of translational research, ensuring the continuation of innovative work in the field. This commitment to education and mentorship is a crucial component of UNMC’s mission to train future leaders in biomedical research.
Focus on Composite Tissue Injuries
Composite tissue injuries, which involve damage to multiple tissue types such as skin, muscle, nerve, and bone, present a significant clinical challenge. Current treatment options are often limited, and regeneration of these complex structures remains a major goal of regenerative medicine. Dr. Wijekoon’s research, in collaboration with Dr. Kumbar’s lab, aims to address this challenge by developing novel technologies for reconstructing and regenerating these injuries. This work has strong translational potential, meaning it could lead to new therapies and improved outcomes for patients suffering from these debilitating conditions.
Dr. Wijekoon’s background in veterinary medicine provides a unique perspective to her research. Her initial training focused on the musculoskeletal system of animals, giving her a strong foundation in anatomy, physiology, and pathology. This expertise, combined with her advanced training in stem cell biology and regenerative medicine, positions her as a leader in the field of joint disease and tissue regeneration. Nebraska Center for Materials & Nanoscience provides further details on her research interests.
As Dr. Wijekoon’s research progresses, the focus will likely remain on refining and testing new therapeutic strategies for nerve and tissue regeneration. The next steps involve preclinical studies to evaluate the safety and efficacy of these approaches, paving the way for potential clinical trials. The ongoing collaboration with Dr. Kumbar and Dr. Abdulmalik will be crucial in translating these discoveries into tangible benefits for patients.
This research represents a significant step forward in the field of regenerative medicine, offering hope for improved treatments for a wide range of injuries and diseases. We encourage readers to share this article and engage in discussions about the future of biomedical research.
Disclaimer: The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. We see essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
